Profile | GDS4284 / 203231_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2600.66 | 87 |
GSM687648 | Patient 402 control | 1476.28 | 79 |
GSM687653 | Patient 403 control | 7648.15 | 96 |
GSM687658 | Patient 404 control | 1728.86 | 82 |
GSM687663 | Patient 411 control | 5496.86 | 94 |
GSM687668 | Patient 422 control | 5242.05 | 94 |
GSM687673 | Patient 424 control | 5698.95 | 94 |
GSM687678 | Patient 425 control | 8456.87 | 97 |
GSM687683 | Patient 427 control | 6410.74 | 95 |
GSM687688 | Patient 428 control | 3555.5 | 90 |
GSM687695 | Patient 441 control | 2549.31 | 88 |
GSM687699 | Patient 443 control | 5151.01 | 94 |
GSM687704 | Patient 444 control | 2903.57 | 88 |
GSM687707 | Patient 448 control | 5194.69 | 94 |
GSM687712 | Patient 449 control | 5083.91 | 93 |
GSM687719 | Patient 450 control | 1944.4 | 84 |
GSM687724 | Patient 451 control | 9634.31 | 97 |
GSM687728 | Patient 452 control | 9657 | 97 |
GSM687646 | Patient 401 treated 24h | 3061.21 | 89 |
GSM687649 | Patient 402 treated 24h | 1751.9 | 82 |
GSM687665 | Patient 411 treated 24h | 5319.02 | 94 |
GSM687651 | Patient 402 treated 4 weeks | 2048.02 | 84 |
GSM687667 | Patient 411 treated 4 weeks | 4727.22 | 93 |
GSM687670 | Patient 422 treated 24h | 5003.84 | 93 |
GSM687671 | Patient 422 treated 4 weeks | 4980.79 | 93 |
GSM687654 | Patient 403 treated 24h | 8193.3 | 96 |
GSM687675 | Patient 424 treated 24h | 5483.06 | 94 |
GSM687685 | Patient 427 treated 24h | 7358.36 | 96 |
GSM687656 | Patient 403 treated 4 weeks | 8195.95 | 96 |
GSM687677 | Patient 424 treated 4 weeks | 6464.08 | 95 |
GSM687687 | Patient 427 treated 4 weeks | 5682.63 | 94 |
GSM687692 | Patient 428 treated 4h | 2119.46 | 85 |
GSM687716 | Patient 449 treated 4h | 5102.04 | 93 |
GSM687722 | Patient 450 treated 4h | 2376.14 | 86 |
GSM687680 | Patient 425 treated 24h | 9426.85 | 97 |
GSM687690 | Patient 428 treated 24h | 2092.65 | 85 |
GSM687700 | Patient 443 treated 24h | 5067.89 | 94 |
GSM687705 | Patient 444 treated 24h | 3383.15 | 90 |
GSM687714 | Patient 449 treated 24h | 4905.38 | 93 |
GSM687721 | Patient 450 treated 24h | 1743.28 | 82 |
GSM687682 | Patient 425 treated 4 weeks | 12676.8 | 98 |
GSM687694 | Patient 428 treated 4 weeks | 2014.31 | 84 |
GSM687702 | Patient 443 treated 4 weeks | 5148.04 | 94 |
GSM687718 | Patient 449 treated 4 weeks | 4863.47 | 93 |
GSM687723 | Patient 450 treated 4 weeks | 2157.49 | 85 |
GSM687661 | Patient 404 treated 4h | 1449.81 | 79 |
GSM687710 | Patient 448 treated 4h | 5751.22 | 94 |
GSM687726 | Patient 451 treated 4h | 9817.52 | 97 |
GSM687730 | Patient 452 treated 4h | 4197.13 | 93 |
GSM687660 | Patient 404 treated 24h | 1802.3 | 84 |
GSM687697 | Patient 441 treated 24h | 4704.98 | 93 |
GSM687709 | Patient 448 treated 24h | 5025.68 | 93 |
GSM687725 | Patient 451 treated 24h | 8016.48 | 96 |
GSM687729 | Patient 452 treated 24h | 13341.7 | 98 |
GSM687727 | Patient 451 treated 4 weeks | 13680.9 | 98 |
GSM687731 | Patient 452 treated 4 weeks | 8494.13 | 96 |